The analysis also reported an increase in Alzheimer’s drugs in development from 2016 to 2017.
Browsing: Cognitive/neurodegenerative disorders
While at AAIC 2017 in London, Lauren Pulling (Editor, NC) spoke to Julie Williams about her extensive work in Alzheimer’s genetics and risk factors.
Findings from four large, population-based studies have further confirmed the importance of good dietary practices in maintaining healthy brain function and reducing dementia risk.
Studies from University of Wisconsin highlight expanded risk factors for cognitive decline and Alzheimer’s disease
Non-elective hospital admissions found to result in a 60% rate of cognitive decline in data presented at AAIC 2017
20 US states identified as ‘dementia neurology deserts’ in data presented at the 2017 Alzheimer’s Association International Conference
A series of studies presented at AAIC have demonstrated that risk factors for dementia, such as early-life stress, may disproportionately affect African Americans, contributing to racial disparity in dementia risk.
Researchers at the University of Alabama at Birmingham (Birmingham, AL, USA) have demonstrated that a small-molecule BDNF mimetic, previously shown to aid respiratory problems in Rett Syndrome, also improves spatial memory and motor function.
Dr Vitek discusses the Neuromodulation Research Center, progression in the field, and the biggest challenges associated with developing new neuromodulation therapies for conditions such as Parkinson’s disease.
The enzyme asparagine endopeptidase could be a key mediator in the cleavage and aggregation of alpha-synuclein in Parkinson’s disease.